107 related articles for article (PubMed ID: 9133448)
1. DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
Romain S; Martin PM; Klijn JG; van Putten WL; Look MP; Guirou O; Foekens JA
Int J Cancer; 1997 Apr; 74(2):156-61. PubMed ID: 9133448
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
[TBL] [Abstract][Full Text] [Related]
3. Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter study.
Romain S; Spyratos F; Descotes F; Daver A; Rostaing-Puissant B; Bougnoux P; Colonna M; Bolla M; Martin PM
Int J Cancer; 2000 Sep; 87(6):860-8. PubMed ID: 10956398
[TBL] [Abstract][Full Text] [Related]
4. Relative activities of thymidylate synthetase and thymidine kinase in human mammary tumours.
Sakamoto S; Ebuchi M; Iwama T
Anticancer Res; 1993; 13(1):205-7. PubMed ID: 8476214
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer.
Romain S; Christensen IJ; Chinot O; Balslev I; Rose C; Martin PM; Thorpe SM
Int J Cancer; 1995 Mar; 61(1):7-12. PubMed ID: 7705935
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
Romain S; Chinot O; Klijn JG; van Putten WL; Guirou O; Look M; Martin PM; Foekens JA
Br J Cancer; 1994 Aug; 70(2):304-8. PubMed ID: 8054279
[TBL] [Abstract][Full Text] [Related]
7. [Thymidine kinase and thymidylate synthetase activities in human gastric cancer].
Kawachi Y
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):993-9. PubMed ID: 8246876
[TBL] [Abstract][Full Text] [Related]
8. DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients.
Romain S; Bendahl PO; Guirou O; Malmström P; Martin PM; Fernö M
Int J Cancer; 2001 Jan; 95(1):56-61. PubMed ID: 11241312
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of thymidylate synthase expression in early breast cancer.
Pestalozzi BC; Peterson HF; Gelber RD; Goldhirsch A; Gusterson BA; Trihia H; Lindtner J; Cortés-Funes H; Simmoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Allegra CJ; Johnston PG
J Clin Oncol; 1997 May; 15(5):1923-31. PubMed ID: 9164203
[TBL] [Abstract][Full Text] [Related]
10. [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities].
Spyratos F; Romain S; Rostaing-Puissant B; Daver A; Collona M; Descotes F; Martin PM; Bougnoux P; Roth H; Bolla M
Bull Cancer; 1999; 86(7-8):678-84. PubMed ID: 10477385
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological stages and pyrimidine nucleotide synthesis in human mammary carcinomas.
Ebuchi M; Sakamoto S; Kudo H; Nagase J; Endo M
Anticancer Res; 1995; 15(4):1481-4. PubMed ID: 7654036
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.
Shintani M; Urano M; Takakuwa Y; Kuroda M; Kamoshida S
Oncol Rep; 2010 May; 23(5):1345-50. PubMed ID: 20372850
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors.
Kralovánszky J; Köves I; Orosz Z; Katona C; Tóth K; Rahóty P; Czeglédi F; Kovács T; Budai B; Hullán L; Jeney A
Oncology; 2002; 62(2):167-74. PubMed ID: 11914603
[TBL] [Abstract][Full Text] [Related]
15. [Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas].
Sakamoto S; Kudo H; Kuwa K; Kawasaki T; Kasahara N; Okamoto R; Sagara T; Kawachi Y; Iwama T; Hirayama R
Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):94-8. PubMed ID: 2500492
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthetase and thymidine kinase activities and methotrexate cytotoxicity during growth of L1210 and Ehrlich ascites tumor.
Hullán L; Szikla K; Tusnády G; Holczinger L
Cancer Biochem Biophys; 1988 Nov; 10(2):131-9. PubMed ID: 3252959
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.
Broët P; Romain S; Daver A; Ricolleau G; Quillien V; Rallet A; Asselain B; Martin PM; Spyratos F
J Clin Oncol; 2001 Jun; 19(11):2778-87. PubMed ID: 11387348
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase predicts for clinical outcome in invasive breast cancer.
Yu Z; Sun J; Zhen J; Zhang Q; Yang Q
Histol Histopathol; 2005 Jul; 20(3):871-8. PubMed ID: 15944938
[TBL] [Abstract][Full Text] [Related]
19. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells.
Xu YZ; Plunkett W
J Biol Chem; 1993 Oct; 268(30):22363-8. PubMed ID: 8226747
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer.
Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Satoh A; Mizumoto T; Hamamoto R
Anticancer Res; 1999; 19(6C):5621-6. PubMed ID: 10697629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
